Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action

@article{Vollenweider1998PsilocybinIS,
  title={Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action},
  author={F. Vollenweider and M. F. Vollenweider-Scherpenhuyzen and A. B{\"a}bler and H. Vogel and D. Hell},
  journal={NeuroReport},
  year={1998},
  volume={9},
  pages={3897–3902}
}
  • F. Vollenweider, M. F. Vollenweider-Scherpenhuyzen, +2 authors D. Hell
  • Published 1998
  • Psychology, Medicine
  • NeuroReport
    • PSILOCYBIN, an indoleamine hallucinogen, produces a psychosis-like syndrome in humans that resembles first episodes of schizophrenia. In healthy human volunteers, the psychotomimetic effects of psilocybin were blocked dose-dependently by the serotonin-2A antagonist ketanserin or the atypical antipsychotic risperidone, but were increased by the dopamine antagonist and typical antipsychotic haloperidol. These data are consistent with animal studies and provide the first evidence in humans that… CONTINUE READING
    View on Wolters Kluwer
    en.psilosophy.info
    504 Citations
    Highly Influential Citations
    23
    Background Citations
    226
    Methods Citations
    15
    Results Citations
    22
    504 Citations
    Citation Type

    Citation Type

    Crosstalk Between 5-HT2A and mGlu2 Receptors: Implications in Schizophrenia and Its Treatment
    • 3
    Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.
    • 18
    • Highly Influenced
    • PDF
    Psychedelics and schizophrenia
    • 130
    Serotonergic Hallucinogens and Emerging Targets for Addiction
    • 1
    • PDF
    Electrophysiology of 5-HT2A Receptors and Relevance for Hallucinogen and Atypical Antipsychotic Drug Actions
    • 2
    Serotonin and serotonin receptors in hallucinogen action
    • 19
    Animal Models and Hallucinogenic Drugs
    • 3
    Animal models of serotonergic psychedelics.
    • 79
    Serotonin-Related Psychedelic Drugs
    • 12
    Alterations of serotonin transmission in schizophrenia.
    • A. Abi-Dargham
    • Psychology, Medicine
    • International review of neurobiology
    • 2007
    • 77

    References

    SHOWING 1-10 OF 13 REFERENCES
    The mechanism of action of novel antipsychotic drugs.
    • H. Meltzer
    • Psychology, Medicine
    • Schizophrenia bulletin
    • 1991
    • 370
    • PDF
    LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    • 123
    Dreams, hallucinogenic drug states, and schizophrenia: a psychological and biological comparison.
    • L. Fischman
    • Psychology, Medicine
    • Schizophrenia bulletin
    • 1983
    • 83
    • PDF
    Alterations in the cortical serotonergic system in schizophrenia: A postmortem study
    • 185
    DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT(2A) and not by 5-HT(2C) receptors.
    • 70
    Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    • 148
    The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.
    • 153
    "Psychedelic" experiences in acute psychoses.
    • 162
    Schizophrenics show spatial working memory deficits.
    • 924
    • PDF
    5-hydroxytryptamine receptor interactions of D-lysergic acid diethylamide.In: Pletscher A and Ladewig D, eds. 50 Years of LSD
    • Current Status and Perspectives of Hallucinogens. New York: Parthenon Publishing,
    • 1994